BAT to Invest CAD 187.5 Million in Organigram Through Private Placement

By Public Technologies14:16 (UTC), 3 November 2026 Updated

British American Tobacco will subscribe for 141,000,000 Organigram shares at CAD 1.33 each through a concurrent private placement.
The investment will raise GBP 100 million (CAD 187.5 million) to fund the Aurora acquisition’s cash consideration and transaction expenses.
The acquisition values Aurora at approximately CAD 561 million, with consideration of CAD 7.80 per share.
BAT will receive non-voting Class A convertible preferred shares instead of common shares where its common-share ownership would exceed 30%.
The placement will close concurrently with the acquisition, expected in January 2027, subject to shareholder, regulatory and court approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrganiGram Global Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261103746636) on November 03, 2026, and is solely responsible for the information contained therein.